Tubeless Versus Standard Upper Pole Percutaneous Nephrolithotomy
NCT ID: NCT02036398
Last Updated: 2018-11-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
75 participants
INTERVENTIONAL
2013-01-31
2017-04-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Prospective Comparison Between Ureteral Stent and Nephrostomy Tube for an Urgent Drainage of Obstructed Kidney
NCT00739284
Tandem Polyurethane Stents Compared to Single Silicone Stent for Malignant Ureteral Obstruction
NCT05992363
Effect of Double J Stent on Outcomes of Extracorporeal Shock Wave Lithotripsy
NCT03636516
Quality of Life in Patients With Double Loop Ureteral Stent (JJ Silicone Hydrogel Study)
NCT02489656
Comparing Previously Placed Nephrostomy Tract (NT) Versus Single Stage Percutaneous Nephrolithotomy (PCNL)
NCT00907946
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nephrostomy tube + double J stent
Standard therapy group with nephrostomy tube and double J stent left at the end of the PCNL
Double J stent without nephrostomy
Double J stent only left at the end of the procedure without placement of a nephrostomy tube
nephrostomy tube and double J stent
Double J stent and nephrostomy tube left at end of procedure
Double J stent without nephrostomy
Double J stent only left at the end of the procedure
Double J stent without nephrostomy
Double J stent only left at the end of the procedure without placement of a nephrostomy tube
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Double J stent without nephrostomy
Double J stent only left at the end of the procedure without placement of a nephrostomy tube
nephrostomy tube and double J stent
Double J stent and nephrostomy tube left at end of procedure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients unwilling to participate in the study
* Patients that nephrostomy tube placement was a prerequisite at the end of the procedure
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rabin Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hanan Goldberg
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hanan Goldberg, MD
Role: PRINCIPAL_INVESTIGATOR
Rabin Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Urology department, Rabin Medical Center
Petach Tiqva, , Israel
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Goldberg H, Nevo A, Shtabholtz Y, Lubin M, Baniel J, Margel D, Ehrlich Y, Lifshitz D. Tubeless supra-costal percutaneous nephrolithotomy is associated with significantly less hydrothorax: a prospective randomized clinical study. BJU Int. 2020 Feb;125(2):276-283. doi: 10.1111/bju.14950. Epub 2019 Dec 3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RMC-6405
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.